Evolus, Inc. (EOLS) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, everyone, and thank you for standing by. Welcome to Evalyst's second quarter earnings conference call. If you require operator assistance during the conference, please press star zero. As a reminder, today's conference is being recorded and webcast live. All participants are in a listen-only mode. After the speaker's remarks, there will be a question and answer session. I would now like to turn the conference over to Narek Segarian, Vice President, and Head of Global Investor Relations and Corporate Communications. Please go ahead. Thank you, Operator, and welcome to everyone joining us on today's call to review Evelis' second quarter financial results. Our second quarter press release is now on our website at evelis.com. With me today are David Modazzetti, President and Chief Executive Officer, and Louis Avalar, Chief Medical Officer and Head of R&D. Today's call will include forward-looking statements. Actual results may differ materially due to risks and uncertainties outlined in our earnings press release and SEC filings. These forward-looking statements are based on current assumptions, and we undertake no obligation to update them. Additionally, we will discuss certain non-GAAP financial measures. These measures should be considered in addition to and not as a substitute for our GAAP results. A reconciliation of GAAP to non-GAAP measures is included in today's earnings release. As a reminder, our earnings release and SEC filings are available on the SEC's website and on our investor relations website. Following the conclusion of today's call, a replay will be available on our website at investors.evalus.com. With that, I'll turn the call over to our CEO, David Modizetti. Thank you, Narek, and good afternoon, everyone. Our second quarter results ...